These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2937870)

  • 61. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Contraception; 1992 Apr; 45(4):299-312. PubMed ID: 1387601
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of a long-acting contraceptive progestogen on lactation.
    Zañartu J; Aguilera E; Muñoz G; Peliowsky H
    Obstet Gynecol; 1976 Feb; 47(2):174-6. PubMed ID: 943074
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The discordance between planned use and actual receipt of immediate postpartum depot medroxyprogesterone among low-income women.
    Brownell EA; Lussier MM; Dozier AM; Howard CR; Fisher SG; Duckett JW; Lawrence RA; Fernandez ID
    Breastfeed Med; 2014; 9(6):290-3. PubMed ID: 24893264
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years.
    Bahamondes L; Del Castillo S; Tabares G; Arce XE; Perrotti M; Petta C
    Contraception; 2001 Oct; 64(4):223-5. PubMed ID: 11747871
    [TBL] [Abstract][Full Text] [Related]  

  • 65. DMPA and breast cancer: the dog has had its day.
    Lancet; 1991 Oct; 338(8771):856-7. PubMed ID: 1681220
    [No Abstract]   [Full Text] [Related]  

  • 66. Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma.
    Harmon QE; Patchel SA; Zhao S; Umbach DM; Cooper TE; Baird DD
    Obstet Gynecol; 2022 May; 139(5):797-807. PubMed ID: 35576339
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Cycle disturbances, galactorrhea and prolactin].
    Wyss HI
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():82-92. PubMed ID: 35482
    [No Abstract]   [Full Text] [Related]  

  • 68. Pharmacodynamic effects of depot-medroxyprogesterone acetate (DMPA) administered to lactating women on their male infants.
    Virutamasen P; Leepipatpaiboon S; Kriengsinyot R; Vichaidith P; Muia PN; Sekadde-Kigondu CB; Mati JK; Forest MG; Dikkeschei LD; Wolthers BG; d'Arcangues C
    Contraception; 1996 Sep; 54(3):153-7. PubMed ID: 8899256
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Association between Immediate Postpartum Depot Medroxyprogesterone Acetate Use and Postpartum Depressive Symptoms.
    Ross CM; Shim JY; Stark EL; Wisner KL; Miller ES
    Am J Perinatol; 2023 Dec; 40(16):1765-1769. PubMed ID: 34775585
    [TBL] [Abstract][Full Text] [Related]  

  • 70. DMPA, zalcitabine, and the FDA.
    Lancet; 1992 Jul; 340(8810):45. PubMed ID: 1351613
    [No Abstract]   [Full Text] [Related]  

  • 71. A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction.
    Said S; Omar K; Koetsawang S; Kiriwat O; Srisatayapan Y; Kazi A; Ajmal F; Wynter HH; Pretnar-Darovec A; Benitez IB
    Contraception; 1986 Sep; 34(3):223-35. PubMed ID: 2947777
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Depot medroxyprogesterone and risk of breast cancer.
    Gray RH
    BMJ; 1989 Oct; 299(6707):1099. PubMed ID: 2531619
    [No Abstract]   [Full Text] [Related]  

  • 73. [Variation of weigth among users of the contraceptive with depot-medroxyprogesterone acetate according to body mass index in a six-year follow-up].
    Pantoja M; Medeiros T; Baccarin MC; Morais S; Fernandes AM
    Rev Bras Ginecol Obstet; 2009 Aug; 31(8):380-4. PubMed ID: 19838585
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety of depot medroxyprogesterone acetate.
    Bonhomme MG; Potts DM; Fortney JA; Allen MY
    Lancet; 1991 Oct; 338(8772):942. PubMed ID: 1681281
    [No Abstract]   [Full Text] [Related]  

  • 75. The effect of immediate postpartum depot medroxyprogesterone on early breastfeeding cessation.
    Brownell EA; Fernandez ID; Fisher SG; Howard CR; Ternullo SR; Lawrence RA; Duckett JW; Dozier AM
    Contraception; 2013 Jun; 87(6):836-43. PubMed ID: 23153897
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cimetidine-induced galactorrhea.
    Ehrinpreis MN; Dhar R; Narula A
    Am J Gastroenterol; 1989 May; 84(5):563-5. PubMed ID: 2719015
    [TBL] [Abstract][Full Text] [Related]  

  • 77. DMPA and bone density.
    Dalton K; Dalton MJ
    BMJ; 1991 Oct; 303(6806):855. PubMed ID: 1834290
    [No Abstract]   [Full Text] [Related]  

  • 78. [Post-partum galactorrhea with hyperprolactinaemia persistent during a clonidine treatment (author's transl)].
    Heim J; Massart C; Auvray E; Allannic H
    Sem Hop; 1979 Dec 8-15; 55(41-42):1933-4. PubMed ID: 231318
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Update on Depo-Provera.
    Sapire KE
    S Afr Med J; 1992 May; 81(9):444-5. PubMed ID: 1533472
    [No Abstract]   [Full Text] [Related]  

  • 80. Contraceptives and cancer--looking for the evidence.
    Cent Afr J Med; 1992 Feb; 38(2):88-9. PubMed ID: 1387044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.